NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES - Provides

NORTH CHICAGO, Ill. , June 20, 2019 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $1.07 per share.  The cash dividend is payable August 15, 2019 to stockholders of record at the close of business on July 15, 2019 .

NORTH CHICAGO, Ill. , June 7, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Goldman Sachs 40 th Annual Global Healthcare Conference on Wednesday, June 12, 2019 . Michael Severino , vice chairman and president, will present at

NORTH CHICAGO, Ill. , May 14, 2019 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the UBS Global Healthcare Conference on Tuesday, May 21, 2019 . Michael Severino , vice chairman and president, will present at 7:30 a.m. Central time .

NORTH CHICAGO, Ill. , May 7, 2019 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019 . Michael Severino , vice chairman and president, will present at 3:00

- Reports First-Quarter Diluted EPS of $1.65 on a GAAP Basis; Adjusted Diluted EPS of $2.14 Reflects Growth of 14.4 Percent - First-Quarter Net Revenues Were $7.828 Billion, an Increase of 0.4 Percent on an Operational Basis, Excluding a 1.7 Percent Unfavorable Impact From Foreign Exchange -

NORTH CHICAGO, Ill. , April 3, 2019 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its first-quarter 2019 financial results on Thursday, April 25 before the market opens. AbbVie will host a live webcast of the earnings conference call at 8

NORTH CHICAGO, Ill. , March 1, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Barclays Global Healthcare Conference on Wednesday, March 13, 2019 . Michael Severino , vice chairman and president, will present at 9:15 a.m.

NORTH CHICAGO, Ill. , Feb. 28, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the 39 th Annual Cowen Health Care Conference on Tuesday, March 12, 2019 . Richard A. Gonzalez , chairman and chief executive officer, will present at 7:00

NORTH CHICAGO, Ill. , Feb. 21, 2019 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE:ABBV) declared a quarterly cash dividend of $1.07 per share. The cash dividend is payable May 15, 2019 to stockholders of record at the close of business on April 15, 2019 .